Cystadrops Solution
Product Images NDC 55292-410

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cystadrops (NDC 55292-410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Recordati Rare Diseases, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Packaging label for Cystadrops 0.37% (cysteamine ophthalmic solution) for topical ophthalmic use. The carton details a 1 x 5 mL sterile solution by Recordati Rare Diseases, Inc. It includes storage, dosage information, active and inactive ingredients, and manufacturing details from Baccinex SA, Switzerland. The label features product identifiers like NDC 55292-410-05 and a barcode.*

FDA Label Image

Figures A, B, C (Figabc)

An instructional diagram showing the step-by-step removal of packaging components from a vial. Figure A depicts removing a green protective cap from a bottle. Figure B shows pulling a tab to remove a metal seal from the vial. Figure C illustrates removing a gray stopper from the vial.*

FDA Label Image

Figures D, E (Figde)

Illustration showing how to attach the dropper with a small white cap to the bottle of CYSTADROPS solution. Figure D depicts aligning and pushing the dropper to attach it to the bottle. Figure E shows the dropper fully attached with the small white cap in place.*

FDA Label Image

Figure F (Figf)

An instructional line drawing illustrating the administration of ophthalmic solution. The illustration shows a hand holding an eye drop bottle dispensing solution into a cupped hand for use with the eye, indicating a step in the eye drop application process.*

FDA Label Image

Figure G (Figg)

An instructional line drawing showing a close-up of a closed eye with a finger gently pulling down the lower eyelid, demonstrating a step in instilling ophthalmic solution drops.*

FDA Label Image

Figure H (Figh)

An instructional diagram labeled Figure H showing a hand gently pulling down the lower eyelid, presumably demonstrating the proper technique for administering ophthalmic solution eye drops.*

FDA Label Image

Label (Label)

Label for Cystadrops ophthalmic solution with 0.37% cysteamine concentration in a 5 mL sterile solution. The label includes the NDC number 55292-410-05, indicates prescription use only, and shows the labeler as Recordati Rare Diseases Inc.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structural Formula (Structure)

Chemical structure of cysteamine hydrochloride, showing the molecular formula with a thiol group (HS), an amine group (NH2), and hydrochloride (HCl). This image represents the active ingredient in CYSTADROPS ophthalmic solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.